Cite
HARVARD Citation
Scheithauer, W. et al. (n.d.). 2089 Response to chemotherapy allows to identify mCRC patients most likely to benefit from maintenance immunotherapy: A post-hoc analysis from the IMPACT study. European journal of cancer. pp. S357-S358. [Online].